Express
Listed Company Sharps Technology Generates Approximately $17.7 Million in Revenue in Q3 Through Pledged Income and Fair Value Gains on Digital Assets
Summary: According to GlobeNewswire, Sharps Technology (STSS), a US-listed medical equipment sales and distribution platform and SOL treasury company, released its Q3 2025 financial report, showing strong execution of its Solana-based financial strategy. The company raised a total revenue of $411 million through PIPE financing, with $267 million in cash and stablecoins, and $144 million in ...
According to GlobeNewswire, Sharps Technology (STSS), a US-listed medical equipment sales and distribution platform and SOL treasury company, released its Q3 2025 financial report, showing strong execution of its Solana-based financial strategy.
The company raised a total revenue of $411 million through PIPE financing, with $267 million in cash and stablecoins, and $144 million in SOL tokens. As of October 31, STSS's treasury holds over 2 million SOL tokens.
In Q3, the company generated approximately $17.7 million in revenue through pledged income and fair value gains on digital assets. As of September 30, the liquidity of cash and stablecoins was approximately $25.2 million.
Chairman Paul K. Danner stated that the successful financing combined with the Solana-based financial strategy has created the strongest balance sheet in the company's history. The company has fully exited the traditional syringe manufacturing business and is focusing on two strategic priorities: medical equipment distribution and maximizing the value of SOL digital asset treasury.
Tags:
Link: Listed Company Sharps Technology Generates Approximately $17.7 Million in Revenue in Q3 Through Pledged Income and Fair Value Gains on Digital Assets [Copy]
